nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Sorafenib—thyroid cancer	0.135	0.225	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.135	0.225	CbGbCtD
Lercanidipine—CYP3A5—Sorafenib—thyroid cancer	0.101	0.169	CbGbCtD
Lercanidipine—CYP3A4—Vandetanib—thyroid cancer	0.0657	0.109	CbGbCtD
Lercanidipine—CYP2D6—Sorafenib—thyroid cancer	0.0622	0.104	CbGbCtD
Lercanidipine—CYP3A4—Sorafenib—thyroid cancer	0.0396	0.0658	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—thyroid cancer	0.0378	0.0628	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—thyroid cancer	0.024	0.0399	CbGbCtD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.0018	0.156	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00159	0.138	CbGpPWpGaD
Lercanidipine—Shock—Sorafenib—thyroid cancer	0.000956	0.00247	CcSEcCtD
Lercanidipine—Nervous system disorder—Sorafenib—thyroid cancer	0.000953	0.00246	CcSEcCtD
Lercanidipine—Dizziness—Vandetanib—thyroid cancer	0.000953	0.00246	CcSEcCtD
Lercanidipine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000952	0.00246	CcSEcCtD
Lercanidipine—Blood urea increased—Epirubicin—thyroid cancer	0.00095	0.00245	CcSEcCtD
Lercanidipine—Skin disorder—Sorafenib—thyroid cancer	0.000944	0.00244	CcSEcCtD
Lercanidipine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000932	0.00241	CcSEcCtD
Lercanidipine—Anorexia—Sorafenib—thyroid cancer	0.000926	0.00239	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000925	0.00239	CcSEcCtD
Lercanidipine—Vomiting—Vandetanib—thyroid cancer	0.000916	0.00237	CcSEcCtD
Lercanidipine—Hyperkalaemia—Doxorubicin—thyroid cancer	0.000915	0.00236	CcSEcCtD
Lercanidipine—Rash—Vandetanib—thyroid cancer	0.000908	0.00235	CcSEcCtD
Lercanidipine—Dermatitis—Vandetanib—thyroid cancer	0.000908	0.00234	CcSEcCtD
Lercanidipine—Headache—Vandetanib—thyroid cancer	0.000903	0.00233	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000885	0.00229	CcSEcCtD
Lercanidipine—Blood urea increased—Doxorubicin—thyroid cancer	0.000879	0.00227	CcSEcCtD
Lercanidipine—Dyspnoea—Sorafenib—thyroid cancer	0.000866	0.00224	CcSEcCtD
Lercanidipine—Lymphadenopathy—Epirubicin—thyroid cancer	0.000857	0.00221	CcSEcCtD
Lercanidipine—Nausea—Vandetanib—thyroid cancer	0.000856	0.00221	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000856	0.00221	CcSEcCtD
Lercanidipine—Dyspepsia—Sorafenib—thyroid cancer	0.000855	0.00221	CcSEcCtD
Lercanidipine—Decreased appetite—Sorafenib—thyroid cancer	0.000845	0.00218	CcSEcCtD
Lercanidipine—Diabetes mellitus—Epirubicin—thyroid cancer	0.00084	0.00217	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000839	0.00217	CcSEcCtD
Lercanidipine—Fatigue—Sorafenib—thyroid cancer	0.000838	0.00216	CcSEcCtD
Lercanidipine—Photosensitivity—Epirubicin—thyroid cancer	0.000832	0.00215	CcSEcCtD
Lercanidipine—Constipation—Sorafenib—thyroid cancer	0.000831	0.00215	CcSEcCtD
Lercanidipine—Hepatic failure—Epirubicin—thyroid cancer	0.000813	0.0021	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000795	0.00205	CcSEcCtD
Lercanidipine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000793	0.00205	CcSEcCtD
Lercanidipine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000777	0.00201	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000774	0.002	CcSEcCtD
Lercanidipine—Urticaria—Sorafenib—thyroid cancer	0.000772	0.00199	CcSEcCtD
Lercanidipine—Photosensitivity—Doxorubicin—thyroid cancer	0.00077	0.00199	CcSEcCtD
Lercanidipine—Body temperature increased—Sorafenib—thyroid cancer	0.000768	0.00198	CcSEcCtD
Lercanidipine—Abdominal pain—Sorafenib—thyroid cancer	0.000768	0.00198	CcSEcCtD
Lercanidipine—Hepatic failure—Doxorubicin—thyroid cancer	0.000752	0.00194	CcSEcCtD
Lercanidipine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000749	0.00193	CcSEcCtD
Lercanidipine—Cardiac failure—Epirubicin—thyroid cancer	0.000749	0.00193	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000746	0.00193	CcSEcCtD
Lercanidipine—Hyponatraemia—Epirubicin—thyroid cancer	0.000734	0.0019	CcSEcCtD
Lercanidipine—Migraine—Epirubicin—thyroid cancer	0.000719	0.00186	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000717	0.00185	CcSEcCtD
Lercanidipine—Hypersensitivity—Sorafenib—thyroid cancer	0.000716	0.00185	CcSEcCtD
Lercanidipine—Face oedema—Epirubicin—thyroid cancer	0.000705	0.00182	CcSEcCtD
Lercanidipine—Asthenia—Sorafenib—thyroid cancer	0.000697	0.0018	CcSEcCtD
Lercanidipine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000693	0.00179	CcSEcCtD
Lercanidipine—Cardiac failure—Doxorubicin—thyroid cancer	0.000693	0.00179	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00069	0.00178	CcSEcCtD
Lercanidipine—Pruritus—Sorafenib—thyroid cancer	0.000688	0.00178	CcSEcCtD
Lercanidipine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000685	0.00177	CcSEcCtD
Lercanidipine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000679	0.00175	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000667	0.00172	CcSEcCtD
Lercanidipine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000667	0.00172	CcSEcCtD
Lercanidipine—Migraine—Doxorubicin—thyroid cancer	0.000666	0.00172	CcSEcCtD
Lercanidipine—Diarrhoea—Sorafenib—thyroid cancer	0.000665	0.00172	CcSEcCtD
Lercanidipine—Breast disorder—Epirubicin—thyroid cancer	0.00066	0.00171	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000658	0.0017	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000658	0.0017	CcSEcCtD
Lercanidipine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000653	0.00169	CcSEcCtD
Lercanidipine—Face oedema—Doxorubicin—thyroid cancer	0.000653	0.00169	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000645	0.00166	CcSEcCtD
Lercanidipine—Muscular weakness—Epirubicin—thyroid cancer	0.000645	0.00166	CcSEcCtD
Lercanidipine—Dizziness—Sorafenib—thyroid cancer	0.000643	0.00166	CcSEcCtD
Lercanidipine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000633	0.00164	CcSEcCtD
Lercanidipine—Asthma—Epirubicin—thyroid cancer	0.000632	0.00163	CcSEcCtD
Lercanidipine—Pancreatitis—Epirubicin—thyroid cancer	0.000619	0.0016	CcSEcCtD
Lercanidipine—Vomiting—Sorafenib—thyroid cancer	0.000618	0.0016	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000618	0.0016	CcSEcCtD
Lercanidipine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000618	0.0016	CcSEcCtD
Lercanidipine—Angina pectoris—Epirubicin—thyroid cancer	0.000615	0.00159	CcSEcCtD
Lercanidipine—Rash—Sorafenib—thyroid cancer	0.000613	0.00158	CcSEcCtD
Lercanidipine—Dermatitis—Sorafenib—thyroid cancer	0.000612	0.00158	CcSEcCtD
Lercanidipine—Breast disorder—Doxorubicin—thyroid cancer	0.000611	0.00158	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000609	0.00157	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000609	0.00157	CcSEcCtD
Lercanidipine—Headache—Sorafenib—thyroid cancer	0.000609	0.00157	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000605	0.00156	CcSEcCtD
Lercanidipine—Pancytopenia—Epirubicin—thyroid cancer	0.0006	0.00155	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—thyroid cancer	0.000596	0.00154	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000596	0.00154	CcSEcCtD
Lercanidipine—Neutropenia—Epirubicin—thyroid cancer	0.000591	0.00153	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—thyroid cancer	0.000584	0.00151	CcSEcCtD
Lercanidipine—Pollakiuria—Epirubicin—thyroid cancer	0.000583	0.00151	CcSEcCtD
Lercanidipine—Nausea—Sorafenib—thyroid cancer	0.000577	0.00149	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000577	0.00149	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—thyroid cancer	0.000573	0.00148	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—thyroid cancer	0.000569	0.00147	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000558	0.00144	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—thyroid cancer	0.000555	0.00143	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—thyroid cancer	0.000554	0.00143	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000552	0.00143	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—thyroid cancer	0.000549	0.00142	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—thyroid cancer	0.000549	0.00142	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—thyroid cancer	0.000546	0.00141	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—thyroid cancer	0.00054	0.00139	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000533	0.00138	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000533	0.00138	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—thyroid cancer	0.000526	0.00136	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000517	0.00133	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—thyroid cancer	0.000512	0.00132	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000511	0.00132	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—thyroid cancer	0.000508	0.00131	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—thyroid cancer	0.000508	0.00131	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—thyroid cancer	0.000507	0.00131	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—thyroid cancer	0.000506	0.00131	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000499	0.00129	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—thyroid cancer	0.000498	0.00129	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000497	0.00128	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—thyroid cancer	0.000496	0.00128	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000493	0.00127	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000486	0.00126	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.000479	0.0416	CbGpPWpGaD
Lercanidipine—Erythema multiforme—Epirubicin—thyroid cancer	0.000478	0.00123	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—thyroid cancer	0.000472	0.00122	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—thyroid cancer	0.000471	0.00122	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—thyroid cancer	0.000469	0.00121	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—thyroid cancer	0.000469	0.00121	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—thyroid cancer	0.000469	0.00121	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—thyroid cancer	0.000468	0.00121	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000462	0.00119	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000461	0.00119	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00046	0.00119	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—thyroid cancer	0.000459	0.00118	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—thyroid cancer	0.000459	0.00118	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—thyroid cancer	0.000457	0.00118	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000456	0.00118	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—thyroid cancer	0.000447	0.00115	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—thyroid cancer	0.000443	0.00114	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000442	0.00114	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—thyroid cancer	0.00044	0.00114	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—thyroid cancer	0.00044	0.00114	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—thyroid cancer	0.000437	0.00113	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—thyroid cancer	0.000436	0.00113	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000434	0.00112	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—thyroid cancer	0.000434	0.00112	CcSEcCtD
Lercanidipine—Tension—Epirubicin—thyroid cancer	0.000432	0.00112	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—thyroid cancer	0.000431	0.00111	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—thyroid cancer	0.000427	0.0011	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—thyroid cancer	0.000424	0.0011	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—thyroid cancer	0.000423	0.00109	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.000423	0.0367	CbGpPWpGaD
Lercanidipine—Immune system disorder—Doxorubicin—thyroid cancer	0.000423	0.00109	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000422	0.00109	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.000421	0.0365	CbGpPWpGaD
Lercanidipine—Vision blurred—Epirubicin—thyroid cancer	0.000415	0.00107	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—thyroid cancer	0.000413	0.00107	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—thyroid cancer	0.00041	0.00106	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000408	0.00105	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—thyroid cancer	0.000407	0.00105	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—thyroid cancer	0.000407	0.00105	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—thyroid cancer	0.000407	0.00105	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—thyroid cancer	0.0004	0.00103	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—thyroid cancer	0.000399	0.00103	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—thyroid cancer	0.000397	0.00103	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—thyroid cancer	0.000395	0.00102	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—thyroid cancer	0.000395	0.00102	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—thyroid cancer	0.000395	0.00102	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—thyroid cancer	0.000391	0.00101	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—thyroid cancer	0.000389	0.001	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—thyroid cancer	0.000387	0.000999	CcSEcCtD
Lercanidipine—Cough—Epirubicin—thyroid cancer	0.000384	0.000992	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—thyroid cancer	0.000384	0.000991	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000378	0.000976	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—thyroid cancer	0.000376	0.000972	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—thyroid cancer	0.000375	0.000968	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—thyroid cancer	0.000375	0.000968	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—thyroid cancer	0.000375	0.000968	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—thyroid cancer	0.000373	0.000964	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000372	0.000961	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.000372	0.0323	CbGpPWpGaD
Lercanidipine—Discomfort—Epirubicin—thyroid cancer	0.00037	0.000956	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—thyroid cancer	0.000367	0.000949	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—thyroid cancer	0.000366	0.000946	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—thyroid cancer	0.000366	0.000945	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—thyroid cancer	0.000365	0.000943	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—thyroid cancer	0.000362	0.000935	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—thyroid cancer	0.00036	0.000929	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000358	0.000924	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—thyroid cancer	0.000355	0.000918	CcSEcCtD
Lercanidipine—Shock—Epirubicin—thyroid cancer	0.000353	0.000913	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—thyroid cancer	0.000352	0.00091	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000352	0.000908	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—thyroid cancer	0.000351	0.000905	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—thyroid cancer	0.000349	0.000901	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000347	0.000897	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—thyroid cancer	0.000347	0.000895	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—thyroid cancer	0.000347	0.000895	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—thyroid cancer	0.000347	0.000895	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—thyroid cancer	0.000345	0.000892	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000344	0.000889	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—thyroid cancer	0.000343	0.000885	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—thyroid cancer	0.000342	0.000884	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—thyroid cancer	0.000339	0.000876	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—thyroid cancer	0.000336	0.000867	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—thyroid cancer	0.000335	0.000866	CcSEcCtD
Lercanidipine—CACNA1D—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.000334	0.029	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000327	0.000845	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—thyroid cancer	0.000327	0.000845	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000326	0.000842	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000325	0.00084	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—thyroid cancer	0.000325	0.000839	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—thyroid cancer	0.000324	0.000838	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—thyroid cancer	0.000323	0.000834	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—thyroid cancer	0.000323	0.000833	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000321	0.00083	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—thyroid cancer	0.00032	0.000827	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—thyroid cancer	0.000319	0.000825	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—thyroid cancer	0.000317	0.000818	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—thyroid cancer	0.000316	0.000817	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—thyroid cancer	0.000312	0.000806	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—thyroid cancer	0.000311	0.000802	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00031	0.000801	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—thyroid cancer	0.00031	0.0008	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—thyroid cancer	0.000307	0.000793	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000303	0.000782	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—thyroid cancer	0.000301	0.000776	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—thyroid cancer	0.000298	0.000771	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—thyroid cancer	0.000296	0.000765	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—thyroid cancer	0.000296	0.000765	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—thyroid cancer	0.000295	0.000763	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000294	0.000759	CcSEcCtD
Lercanidipine—CACNA1C—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.000294	0.0255	CbGpPWpGaD
Lercanidipine—Dyspepsia—Doxorubicin—thyroid cancer	0.000293	0.000756	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—thyroid cancer	0.000289	0.000746	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000287	0.000741	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—thyroid cancer	0.000287	0.00074	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—thyroid cancer	0.000285	0.000737	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—thyroid cancer	0.000284	0.000734	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—thyroid cancer	0.000284	0.000733	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—thyroid cancer	0.000284	0.000733	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000274	0.000707	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000272	0.000702	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—thyroid cancer	0.000265	0.000684	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—thyroid cancer	0.000264	0.000682	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—thyroid cancer	0.000263	0.000679	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—thyroid cancer	0.000263	0.000679	CcSEcCtD
Lercanidipine—CACNA1D—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000263	0.0228	CbGpPWpGaD
Lercanidipine—Asthenia—Epirubicin—thyroid cancer	0.000258	0.000666	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000254	0.0221	CbGpPWpGaD
Lercanidipine—Pruritus—Epirubicin—thyroid cancer	0.000254	0.000656	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—thyroid cancer	0.000246	0.000635	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000245	0.000632	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—thyroid cancer	0.000238	0.000616	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—thyroid cancer	0.000238	0.000613	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—thyroid cancer	0.000235	0.000607	CcSEcCtD
Lercanidipine—CACNA1C—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000231	0.02	CbGpPWpGaD
Lercanidipine—Vomiting—Epirubicin—thyroid cancer	0.000228	0.00059	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—thyroid cancer	0.000227	0.000587	CcSEcCtD
Lercanidipine—Rash—Epirubicin—thyroid cancer	0.000226	0.000585	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—thyroid cancer	0.000226	0.000584	CcSEcCtD
Lercanidipine—Headache—Epirubicin—thyroid cancer	0.000225	0.000581	CcSEcCtD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000223	0.0194	CbGpPWpGaD
Lercanidipine—Dizziness—Doxorubicin—thyroid cancer	0.00022	0.000568	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—thyroid cancer	0.000213	0.000551	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—thyroid cancer	0.000211	0.000546	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—thyroid cancer	0.00021	0.000541	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—thyroid cancer	0.000209	0.000541	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—thyroid cancer	0.000208	0.000538	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000205	0.0178	CbGpPWpGaD
Lercanidipine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000198	0.0172	CbGpPWpGaD
Lercanidipine—Nausea—Doxorubicin—thyroid cancer	0.000197	0.00051	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000197	0.0171	CbGpPWpGaD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000173	0.015	CbGpPWpGaD
Lercanidipine—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000168	0.0146	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000148	0.0128	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00014	0.0122	CbGpPWpGaD
Lercanidipine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000118	0.0103	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000114	0.00987	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000105	0.00913	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000101	0.0088	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	9.12e-05	0.00791	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MINPP1—thyroid cancer	8.25e-05	0.00716	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.22e-05	0.00714	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	8.01e-05	0.00695	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	7.85e-05	0.00681	CbGpPWpGaD
Lercanidipine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	7.8e-05	0.00677	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—CDK1—thyroid cancer	7.29e-05	0.00633	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MINPP1—thyroid cancer	7.25e-05	0.00629	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.21e-05	0.00626	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NDUFA13—thyroid cancer	7.01e-05	0.00609	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	6.89e-05	0.00598	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	6.88e-05	0.00597	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	6.67e-05	0.00579	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CHST14—thyroid cancer	6.59e-05	0.00572	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—CDK1—thyroid cancer	6.4e-05	0.00556	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TP53—thyroid cancer	6.19e-05	0.00537	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NDUFA13—thyroid cancer	6.16e-05	0.00535	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—RXRA—thyroid cancer	6.04e-05	0.00524	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	5.86e-05	0.00509	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.85e-05	0.00507	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CHST14—thyroid cancer	5.79e-05	0.00503	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TP53—thyroid cancer	5.44e-05	0.00472	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—HPGD—thyroid cancer	5.32e-05	0.00461	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—CDK1—thyroid cancer	5.2e-05	0.00451	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RXRA—thyroid cancer	4.83e-05	0.00419	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.71e-05	0.00409	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.69e-05	0.00407	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HPGD—thyroid cancer	4.67e-05	0.00405	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—CDK1—thyroid cancer	4.57e-05	0.00397	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MINPP1—thyroid cancer	4.44e-05	0.00385	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—RXRA—thyroid cancer	4.37e-05	0.00379	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RXRA—thyroid cancer	4.24e-05	0.00368	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.82e-05	0.00332	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NDUFA13—thyroid cancer	3.77e-05	0.00328	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CHST14—thyroid cancer	3.55e-05	0.00308	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MINPP1—thyroid cancer	3.21e-05	0.00278	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	3.11e-05	0.0027	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TPR—thyroid cancer	3.05e-05	0.00265	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PPARG—thyroid cancer	3.05e-05	0.00265	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PRKAR1A—thyroid cancer	3e-05	0.00261	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HPGD—thyroid cancer	2.86e-05	0.00248	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	2.73e-05	0.00237	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TPR—thyroid cancer	2.68e-05	0.00233	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PPARG—thyroid cancer	2.68e-05	0.00232	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PRKAR1A—thyroid cancer	2.64e-05	0.00229	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—NRAS—thyroid cancer	2.61e-05	0.00227	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CHST14—thyroid cancer	2.56e-05	0.00223	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—NRAS—thyroid cancer	2.3e-05	0.00199	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SLC5A5—thyroid cancer	2.29e-05	0.00198	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.28e-05	0.00198	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—KRAS—thyroid cancer	2.25e-05	0.00195	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HPGD—thyroid cancer	2.07e-05	0.00179	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.03e-05	0.00176	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SLC5A5—thyroid cancer	2.01e-05	0.00174	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—KRAS—thyroid cancer	1.98e-05	0.00172	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.94e-05	0.00168	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—RXRA—thyroid cancer	1.92e-05	0.00167	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—HRAS—thyroid cancer	1.91e-05	0.00166	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—NRAS—thyroid cancer	1.87e-05	0.00162	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CHST14—thyroid cancer	1.82e-05	0.00158	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—RXRA—thyroid cancer	1.69e-05	0.00146	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—HRAS—thyroid cancer	1.68e-05	0.00146	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TPR—thyroid cancer	1.64e-05	0.00143	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—NRAS—thyroid cancer	1.64e-05	0.00142	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.62e-05	0.0014	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KRAS—thyroid cancer	1.61e-05	0.00139	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.49e-05	0.00129	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HPGD—thyroid cancer	1.47e-05	0.00128	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KRAS—thyroid cancer	1.41e-05	0.00122	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—HRAS—thyroid cancer	1.36e-05	0.00118	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.27e-05	0.0011	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.23e-05	0.00107	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PPARG—thyroid cancer	1.21e-05	0.00105	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—AKT1—thyroid cancer	1.21e-05	0.00105	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—HRAS—thyroid cancer	1.2e-05	0.00104	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.19e-05	0.00103	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TPR—thyroid cancer	1.19e-05	0.00103	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.17e-05	0.00101	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PPARG—thyroid cancer	1.07e-05	0.000925	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT1—thyroid cancer	1.06e-05	0.000919	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RXRA—thyroid cancer	1.03e-05	0.000897	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HPGD—thyroid cancer	9.61e-06	0.000834	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—thyroid cancer	9.54e-06	0.000828	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	8.89e-06	0.000771	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TPR—thyroid cancer	8.44e-06	0.000733	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—thyroid cancer	8.38e-06	0.000727	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTEN—thyroid cancer	8.32e-06	0.000722	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	8.31e-06	0.000721	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RXRA—thyroid cancer	7.47e-06	0.000648	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTEN—thyroid cancer	7.31e-06	0.000634	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PPARG—thyroid cancer	6.52e-06	0.000566	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	6.32e-06	0.000549	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TPR—thyroid cancer	5.52e-06	0.000479	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.43e-06	0.000471	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RXRA—thyroid cancer	5.31e-06	0.000461	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—thyroid cancer	5.13e-06	0.000445	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AKT1—thyroid cancer	4.79e-06	0.000416	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PPARG—thyroid cancer	4.72e-06	0.000409	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTEN—thyroid cancer	4.48e-06	0.000388	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AKT1—thyroid cancer	4.21e-06	0.000366	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.13e-06	0.000359	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—thyroid cancer	3.71e-06	0.000322	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RXRA—thyroid cancer	3.47e-06	0.000301	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PPARG—thyroid cancer	3.35e-06	0.000291	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTEN—thyroid cancer	3.24e-06	0.000281	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.64e-06	0.000229	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AKT1—thyroid cancer	2.58e-06	0.000224	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTEN—thyroid cancer	2.3e-06	0.0002	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.19e-06	0.00019	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKT1—thyroid cancer	1.86e-06	0.000162	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.72e-06	0.00015	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.5e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.33e-06	0.000115	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKT1—thyroid cancer	8.67e-07	7.52e-05	CbGpPWpGaD
